{"id":4178,"date":"2016-09-03T04:47:12","date_gmt":"2016-09-03T08:47:12","guid":{"rendered":"https:\/\/medicarereport.org\/?p=4178"},"modified":"2016-09-02T16:49:16","modified_gmt":"2016-09-02T20:49:16","slug":"hurdles-abound-in-race-to-bring-customized-cancer-treatments-to-masses","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=4178","title":{"rendered":"Hurdles abound in race to bring customized cancer treatments to masses"},"content":{"rendered":"<p>(By Meghana Keshavan for ST<em>A<\/em>T)<\/p>\n<p><span class=\"big-cap\">T<\/span>he idea is tantalizing: Reengineer a patient\u2019s own immune cells to attack the cancer that\u2019s killing her. Scientists have proven it can be done, curing patients of otherwise terminal blood cancers. <a href=\"https:\/\/www.statnews.com\/2016\/09\/02\/cancer-immunotherapy-car-t-scale\/\" target=\"_blank\">Continue reading article here&#8230;&#8230;<\/a><\/p>\n<p>&nbsp;<\/p>\n<pre style=\"border: 1px solid #eaeaea; font-variant-ligatures: normal; font-variant-caps: normal; font-variant-numeric: inherit; font-stretch: inherit; line-height: 1.4; font-family: 'Courier 10 Pitch', Courier, monospace; font-size: 14px; font-style: normal; font-weight: normal; margin: 0px 0px 20px; outline: 0px; padding: 20px; vertical-align: baseline; overflow: auto; white-space: pre-wrap; color: #444444; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: #ffffff;\"><strong>Notice<\/strong>: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(By Meghana Keshavan for STAT) The idea is tantalizing: Reengineer a patient\u2019s own immune cells to attack the cancer that\u2019s<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17,15],"tags":[],"class_list":["post-4178","post","type-post","status-publish","format-standard","hentry","category-emerging-health-issues","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/4178","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4178"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/4178\/revisions"}],"predecessor-version":[{"id":4179,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/4178\/revisions\/4179"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4178"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4178"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4178"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}